Micrima: Developing technology for breast cancer screening
A new breast cancer screening method in the future.
Micrima is a Bristol based diagnostic imaging company founded in 2006. Micrima has developed the MARIA® breast cancer screening system. This breast imaging system uses harmless radio-waves to detect breast cancer, unlike mammography that uses ionising radiation. MARIA® also requires no breast compression so is painless for women. It is a whole breast method of imaging compared to some modalities that use a handheld probe. With a handheld system, the operator needs to know where to look for a lesion. It has proven more effective than current imaging methods, particularly in dense tissue. MARIA® has been trialled in over 400 women in the United Kingdom. Further trials are taking place at leading European centres. Currently, MARIA® is being used in symptomatic clinics, it is hoped eventually this will be a viable alternative to mammography in breast screening.
Click here for updates on MARIA® developments.
Latest news
Latest MARIA® trial to begin at Royal Marsden NHS Foundation Trust
LIESL trial initiation photo
We are pleased to announce the MARIA® system has been installed in the Rapid and Diagnostic …
ECR 2018 Micrima’s involvement
Micrima attended with ECR 2018 in Vienna this year with an exhibition booth showing the latest developments to the Radio-wave …
